RedHill Biopharma (RDHL) Short Interest Ratio & Short Volume $2.07 -0.08 (-3.72%) Closing price 05/2/2025 03:59 PM EasternExtended Trading$2.10 +0.03 (+1.45%) As of 05/2/2025 07:32 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock RedHill Biopharma Short Interest DataRedHill Biopharma (RDHL) has a short interest of 26,500 shares, representing 2.09% of the float (the number of shares available for trading by the public). This marks a -11.67% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.1, indicating that it would take 0.1 days of the average trading volume of 147,199 shares to cover all short positions.Current Short Interest26,500 sharesPrevious Short Interest30,000 sharesChange Vs. Previous Month-11.67%Dollar Volume Sold Short$56,445.00Short Interest Ratio0.1 Days to CoverLast Record DateApril 15, 2025Outstanding Shares1,769,000 sharesFloat Size1,270,000 sharesShort Percent of Float2.09%Today's Trading Volume21,685 sharesAverage Trading Volume147,199 sharesToday's Volume Vs. Average15% Short Selling RedHill Biopharma? Sign up to receive the latest short interest report for RedHill Biopharma and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartRDHL Short Interest Over TimeRDHL Days to Cover Over TimeRDHL Percentage of Float Shorted Over Time RedHill Biopharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/202526,500 shares $56,445.00 -11.7%2.1%0.1 $2.13 3/31/202530,000 shares $79,800.00 -35.8%2.4%0.3 $2.66 3/15/202546,700 shares $119,552.00 +37.4%3.7%0.5 $2.56 2/28/202534,000 shares $113,220.00 +486.2%2.7%0.6 $3.33 2/15/20255,800 shares $30,595.00 +9.4%0.5%0.1 $5.28 1/31/20255,300 shares $31,667.50 -43.6%0.4%0.3 $5.98 1/15/20259,400 shares $52,358.00 +62.1%0.7%0.6 $5.57 12/31/20245,800 shares $36,018.00 +9.4%0.5%0.3 $6.21 12/15/20245,300 shares $39,432.00 -5.4%0.4%0.3 $7.44 11/30/20245,600 shares $47,600.00 -17.7%0.4%0.2 $8.50 Get the Latest News and Ratings for RDHL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for RedHill Biopharma and its competitors with MarketBeat's FREE daily newsletter. 11/15/20246,800 shares $49,572.00 +325.0%0.5%0.2 $7.29 10/31/20241,600 shares $13,184.00 -78.4%0.1%0 $8.24 10/15/20247,400 shares $59,940.00 -73.5%0.6%0 $8.10 9/30/202427,900 shares $243,846.00 -44.0%2.2%0.1 $8.74 9/15/202449,800 shares $548,298.00 -58.7%3.9%0.2 $11.01 8/31/2024120,500 shares $1.02 million +455.3%9.5%0.4 $8.50 8/15/202421,700 shares $5.09 million -94.8%1.7%0.1 $234.38 7/31/2024417,400 shares $160,323.34 +23.1%1.3%0.1 $0.38 7/15/2024339,200 shares $135,917.44 -31.0%1.1%1.3 $0.40 6/30/2024491,400 shares $182,161.98 -4.3%1.6%1.7 $0.37 6/15/2024513,700 shares $199,932.55 -7.6%1.6%1.6 $0.39 5/31/2024556,000 shares $254,703.60 -14.5%1.8%1.5 $0.46 5/15/2024650,200 shares $299,092.00 -13.7%2.1%1.4 $0.46 4/30/2024753,600 shares $325,027.68 +1.6%2.4%1.5 $0.43 4/15/2024741,500 shares $299,640.15 -18.2%2.5%0.6 $0.40 3/31/2024906,900 shares $480,566.31 -14.4%3.1%0.7 $0.53 3/15/20241,060,000 shares $558,408.00 +181.8%3.6%0.8 $0.53 2/29/2024376,200 shares $231,363.00 -38.9%1.3%0.2 $0.62 2/15/2024615,700 shares $334,756.09 -44.5%2.1%0.1 $0.54 1/31/20241,110,000 shares $643,800.00 +263.1%3.8%0.1 $0.58 1/15/2024305,700 shares $324,042.00 -57.5%1.6%0 $1.06 12/31/2023720,000 shares $1.05 million +149.3%3.7%0.1 $1.46 12/15/2023288,800 shares $329,232.00 -93.9%1.5%0 $1.14 11/30/20234,740,000 shares $9.48 million +16,188.7%24.2%0.5 $2.00 11/15/202329,100 shares $9,748.50 -90.1%0.3%0 $0.34 10/31/2023293,600 shares $129,184.00 +153.1%2.7%0.2 $0.44 10/15/2023116,000 shares $37,120.00 +590.5%1.1%0.1 $0.32 9/30/202316,800 shares $8,568.00 +200.0%0.3%0 $0.51 9/15/20235,600 shares $4,760.00 -27.3%0.1%0 $0.85 8/31/20237,700 shares $6,768.30 +102.6%0.1%0 $0.88URGENT: Someone's Moving Gold Out of London... (Ad)People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “gold analysts” have it all wrong… They tell you to invest in gold ETFs - because the popular mining ETFs will someday catch fire and close the price gap with spot gold. Go here to learn about my Top Four picks for the coming bull mania. 8/15/20233,800 shares $3,156.66 -85.7%0.1%0 $0.83 7/31/202326,600 shares $34,048.00 -77.7%0.5%0.1 $1.28 7/15/2023119,400 shares $213,726.00 +594.2%4.1%0.6 $1.79 6/30/202317,200 shares $20,640.00 -39.0%0.6%0.1 $1.20 6/15/202328,200 shares $54,990.00 -64.5%1.0%0.3 $1.95 5/31/202379,400 shares $184,208.00 -31.9%2.7%0.8 $2.32 5/15/2023116,600 shares $267,014.00 -31.7%4.0%1.2 $2.29 4/30/2023170,700 shares $414,801.00 +9.4%6.4%1.6 $2.43 4/15/2023156,100 shares $501,081.00 +25.6%5.8%1 $3.21 3/31/2023124,300 shares $508,387.00 -11.7%5.1%0.8 $4.09 3/15/2023140,800 shares $1.01 million -97.8%N/A0.9 $7.16 2/28/20236,410,000 shares $1.45 million -3.0%N/A1.1 $0.23 2/15/20236,610,000 shares $1.41 million -18.5%N/A1.1 $0.21 1/31/20238,110,000 shares $1.77 million +279.0%N/A1.4 $0.22 1/15/20232,140,000 shares $422,650.00 +22.3%N/A0.7 $0.20 12/30/20221,750,000 shares $245,525.00 +32.6%N/A0.4 $0.14 12/15/20221,320,000 shares $252,120.00 -47.6%N/A0.4 $0.19 11/30/20222,520,000 shares $907,200.00 +22.3%N/A0.8 $0.36 11/15/20222,060,000 shares $1.13 million -14.9%N/A0.7 $0.55 10/31/20222,420,000 shares $1.68 million -8.0%N/A0.9 $0.70 10/15/20222,630,000 shares $1.36 million -1.1%N/A0.9 $0.52 9/30/20222,660,000 shares $1.34 million +60.2%N/A1.8 $0.50 9/15/20221,660,000 shares $1.32 million No ChangeN/A0.7 $0.80 8/31/20221,660,000 shares $1.49 million +4.4%N/A0.5 $0.90 8/15/20221,590,000 shares $1.65 million -7.6%N/A0.5 $1.04 7/31/20221,720,000 shares $1.50 million -16.9%N/A0.6 $0.87 7/15/20222,070,000 shares $1.97 million -25.0%N/A0.8 $0.95 6/30/20222,760,000 shares $2.40 million +117.3%N/A1.1 $0.87 6/15/20221,270,000 shares $814,832.00 -17.0%N/A0.7 $0.64 5/31/20221,530,000 shares $1.71 million -5.6%N/A3.8 $1.12 5/15/20221,620,000 shares $1.65 million +2.5%N/A3.9 $1.02 4/30/20221,580,000 shares $2.67 million +7.5%N/A3.9 $1.69 4/15/20221,470,000 shares $2.97 million -3.3%N/A3.7 $2.02 3/31/20221,520,000 shares $3.83 million +3.4%N/A3.4 $2.52 3/15/20221,470,000 shares $2.43 million +5.0%N/A3.1 $1.65 2/28/20221,400,000 shares $3.07 million +1.5%N/A2.6 $2.19 2/15/20221,380,000 shares $3.45 million -14.8%N/A2.2 $2.50 1/31/20221,620,000 shares $4.26 million +26.6%N/A2.2 $2.63 1/15/20221,280,000 shares $3.16 million -23.8%N/A1.7 $2.47 12/31/20211,680,000 shares $4.33 million -17.7%N/A2.1 $2.58 12/15/20212,040,000 shares $5.73 million +10.3%N/A2.1 $2.81 11/30/20211,850,000 shares $5.40 million -21.6%N/A1.7 $2.92 11/15/20212,360,000 shares $10.71 million -14.2%5.1%1.9 $4.54 10/29/20212,750,000 shares $14.96 million +10.9%6.0%2.5 $5.44 10/15/20212,480,000 shares $12.13 million +90.8%5.4%2.3 $4.89 9/30/20211,300,000 shares $5.95 million No Change2.8%1.3 $4.58 9/15/20211,300,000 shares $6.32 million -29.7%2.8%1.6 $4.86 8/31/20211,850,000 shares $18.69 million -8.9%4.0%3.1 $10.10 8/13/20212,030,000 shares $14.41 million +21.6%4.4%6.7 $7.10 7/30/20211,670,000 shares $10.75 million -19.3%3.7%5.8 $6.44Elon’s Terrifying Warning Forces Trump To Take Action (Ad)Elon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of collapse and built two of the most valuable companies in history. Now, he's sounding the alarm about America's $36 trillion debt time bomb that could destroy the fabric of our society.As head of the Department of Government Efficiency (DOGE) under President Trump, Musk is exposing just how bad things are...Get your free gold guide! 7/15/20212,070,000 shares $12.36 million +10.1%N/A7.6 $5.97 6/30/20211,880,000 shares $12.93 million +2.7%N/A7.4 $6.88 6/15/20211,830,000 shares $13.12 million -7.6%N/A6.8 $7.17 5/28/20211,980,000 shares $14.36 million -14.7%N/A6.9 $7.25 5/14/20212,320,000 shares $13.87 million +17.8%N/A6.8 $5.98 4/30/20211,970,000 shares $13.73 million -2.0%N/A4.8 $6.97 4/15/20212,010,000 shares $14.23 million -27.2%N/A3.7 $7.08 3/31/20212,760,000 shares $19.73 million +8.7%N/A4.7 $7.15 3/15/20212,540,000 shares $20.07 million +5.4%N/A4.3 $7.90 2/26/20212,410,000 shares $23.96 million No ChangeN/A4.2 $9.94 2/12/20212,410,000 shares $22.75 million -5.9%N/A4.8 $9.44 1/29/20212,560,000 shares $22.58 million +8.9%N/A5.7 $8.82 1/15/20212,350,000 shares $17.32 million -2.5%N/A5.9 $7.37 12/31/20202,410,000 shares $20.63 million +23.6%N/A7.6 $8.56 12/15/20201,950,000 shares $16.58 million +2.1%N/A7.3 $8.50 11/30/20201,910,000 shares $16.90 million +21.7%N/A6.1 $8.85 11/15/20201,570,000 shares $12.86 million -11.8%N/A4.7 $8.19 10/30/20201,780,000 shares $15.56 million +8.5%N/A5.4 $8.74 10/15/20201,640,000 shares $16.53 million +3.1%N/A4.1 $10.08 9/30/20201,590,000 shares $16.25 million -20.5%N/A4 $10.22 9/15/20202,000,000 shares $21.52 million +1.0%59.9%4.7 $10.76 8/31/20201,980,000 shares $16.35 million -4.4%59.3%5 $8.26 8/14/20202,070,000 shares $16.10 million -2.4%N/A5.7 $7.78 7/31/20202,120,000 shares $16.81 million +5.0%N/A6 $7.93 7/15/20202,020,000 shares $12.89 million +12.2%N/A5.3 $6.38 6/30/20201,800,000 shares $12.64 million +7.8%N/A4 $7.02 6/15/20201,670,000 shares $11.57 million -2.3%N/A3.7 $6.93 5/29/20201,710,000 shares $11.88 million +1.8%N/A3.8 $6.95 5/15/20201,680,000 shares $11.29 million +5.0%N/A3.6 $6.72 RDHL Short Interest - Frequently Asked Questions What is RedHill Biopharma's current short interest? Short interest is the volume of RedHill Biopharma shares that have been sold short but have not yet been covered or closed out. As of April 15th, investors have sold 26,500 shares of RDHL short. 2.09% of RedHill Biopharma's shares are currently sold short. Learn More on RedHill Biopharma's current short interest. Which institutional investors are shorting RedHill Biopharma? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of RedHill Biopharma: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for RedHill Biopharma? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.09% of RedHill Biopharma's floating shares are currently sold short. Is RedHill Biopharma's short interest increasing or decreasing? RedHill Biopharma saw a drop in short interest during the month of April. As of April 15th, there was short interest totaling 26,500 shares, a drop of 11.7% from the previous total of 30,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is RedHill Biopharma's float size? RedHill Biopharma currently has issued a total of 1,769,000 shares. Some of RedHill Biopharma's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. RedHill Biopharma currently has a public float of 1,270,000 shares. How does RedHill Biopharma's short interest compare to its competitors? 2.09% of RedHill Biopharma's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to RedHill Biopharma: ProPhase Labs, Inc. (6.76%), IN8bio, Inc. (0.74%), ImmunoPrecise Antibodies Ltd. (5.18%), TherapeuticsMD, Inc. (1.29%), GeoVax Labs, Inc. (9.28%), Moleculin Biotech, Inc. (3.32%), Trinity Biotech plc (0.96%), Cellectar Biosciences, Inc. (4.99%), Marker Therapeutics, Inc. (2.64%), NeuroSense Therapeutics Ltd. (1.21%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.71 billion), iShares 20+ Year Treasury Bond ETF ($9.48 billion), Strategy Incorporated ($8.92 billion), Charter Communications, Inc. ($3.86 billion), Apollo Global Management, Inc. ($3.86 billion), Capital One Financial Co. ($3.72 billion), Super Micro Computer, Inc. ($3.47 billion), AppLovin Co. ($2.64 billion), VanEck Semiconductor ETF ($2.46 billion), and The Kroger Co. ($2.33 billion). View all of the most shorted stocks. What does it mean to sell short RedHill Biopharma stock? Short selling RDHL is an investing strategy that aims to generate trading profit from RedHill Biopharma as its price is falling. RDHL shares are trading down $0.08 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against RedHill Biopharma? A short squeeze for RedHill Biopharma occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of RDHL, which in turn drives the price of the stock up even further. How often is RedHill Biopharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including RDHL, twice per month. The most recent reporting period available is April, 15 2025. More Short Interest Resources from MarketBeat Related Companies ProPhase Labs Short Interest Data IN8bio Short Interest Data ImmunoPrecise Antibodies Short Interest Data TherapeuticsMD Short Interest Data GeoVax Labs Short Interest Data Moleculin Biotech Short Interest Data Trinity Biotech Short Interest Data Cellectar Biosciences Short Interest Data Marker Therapeutics Short Interest Data NeuroSense Therapeutics Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:RDHL) was last updated on 5/4/2025 by MarketBeat.com Staff From Our PartnersThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | SponsoredWill May start the next "Great Depression?"You probably haven't heard about this yet... But this could be the biggest wealth building opportunity of t...Behind the Markets | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAII predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding RedHill Biopharma Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share RedHill Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
